109 related articles for article (PubMed ID: 2868070)
1. Human cerebrospinal fluid somatostatin in neurologic disease.
Beal MF; Mazurek MF; Black PM; Martin JB
J Neurol Sci; 1985 Nov; 71(1):91-104. PubMed ID: 2868070
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid levels of immunoreactive substance P and somatostatin in patients with multiple sclerosis and inflammatory CNS disease.
Rösler N; Reuner C; Geiger J; Rissler K; Cramer H
Peptides; 1990; 11(1):181-3. PubMed ID: 1692993
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin-like immunoreactivity (NTLI) concentration in the cerebrospinal fluid of children and its alteration in a febrile aseptic meningitis.
Muraki K; Nishi Y; Okahata H; Arai M; Yamada H; Fujita S; Miyachi Y; Ueda K; Yamawaki S; Yajima H
Life Sci; 1987 Apr; 40(14):1365-70. PubMed ID: 3561155
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid (CSF) neuropeptide Y- and somatostatin-like immunoreactivities in man.
Maeda K; Yasuda M; Kaneda H; Maeda S; Yamadori A
Neuropeptides; 1994 Dec; 27(6):323-32. PubMed ID: 7898640
[TBL] [Abstract][Full Text] [Related]
5. Evidence for somatostatin precursors in human stomach, placenta, and amniotic fluid.
Fitz-Patrick D; Patel YC
J Clin Endocrinol Metab; 1981 Aug; 53(2):372-6. PubMed ID: 6114109
[TBL] [Abstract][Full Text] [Related]
6. Ventricular fluid neuropeptides in Parkinson's disease. I. Levels and distribution of somatostatin-like immunoreactivity.
Jost S; Reuner C; Mohadjer M; Mundinger F; Cramer H
Neuropeptides; 1990 Apr; 15(4):219-25. PubMed ID: 1979661
[TBL] [Abstract][Full Text] [Related]
7. A long-term follow-up study of cerebrospinal fluid somatostatin in delirium.
Koponen HJ; Leinonen E; Lepola U; Riekkinen PJ
Acta Psychiatr Scand; 1994 May; 89(5):329-34. PubMed ID: 7915078
[TBL] [Abstract][Full Text] [Related]
8. CSF somatostatin increase in patients with early parkinsonian syndrome.
Espino A; Calopa M; Ambrosio S; Ortolà J; Peres J; Navarro MA
J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):189-96. PubMed ID: 8527003
[TBL] [Abstract][Full Text] [Related]
9. Measurement, characterization, and source of somatostatin-like immunoreactivity in human amniotic fluid.
Fitz-Patrick D; Patel YC
J Clin Invest; 1979 Sep; 64(3):737-42. PubMed ID: 468988
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.
Cramer H; Schaudt D; Rissler K; Strubel D; Warter JM; Kuntzmann F
J Neurol; 1985; 232(6):346-51. PubMed ID: 2416886
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin-like immunoreactivity in human peripheral plasma measured by radioimmunoassay following affinity chromatography.
Tsuda K; Sakurai H; Seino Y; Seino S; Tanigawa K; Kuzuya H; Imura H
Diabetes; 1981 Jun; 30(6):471-4. PubMed ID: 6112180
[TBL] [Abstract][Full Text] [Related]
12. CSF somatostatin-like immunoreactivity in dementia.
Beal MF; Growdon JH; Mazurek MF; Martin JB
Neurology; 1986 Feb; 36(2):294-7. PubMed ID: 2868429
[TBL] [Abstract][Full Text] [Related]
13. Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
Strittmatter M; Cramer H; Reuner C; Strubel D; Hamann G; Schimrigk K
Biol Psychiatry; 1997 Jun; 41(11):1124-30. PubMed ID: 9146823
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin in human cerebrospinal fluid.
Patel Y; Rao K; Reichlin S
N Engl J Med; 1977 Mar; 296(10):529-33. PubMed ID: 836537
[TBL] [Abstract][Full Text] [Related]
15. Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease.
Rissler K; Cramer H; Schaudt D; Strubel D; Gattaz WF
Neurosci Res; 1986 Feb; 3(3):213-25. PubMed ID: 2871533
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease.
Cramer H; Rösler N; Rissler K; Gagnieu MC; Renaud B
Neuropeptides; 1988 Oct; 12(3):119-24. PubMed ID: 2468107
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin-like immunoreactivity in the cerebrospinal fluid of neurological patients.
Kohler J; Schröter E; Cramer H
Arch Psychiatr Nervenkr (1970); 1982; 231(6):503-8. PubMed ID: 6127989
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin-like immunoreactivity (SLI) in cisternal cerebrospinal fluid of rats kindled by pentylenetetrazol.
Pitkänen A; Jolkkonen J; Riekkinen PJ
Brain Res; 1987 Jul; 416(1):180-2. PubMed ID: 2887246
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid somatostatin in delirium. II. Changes at the acute stage and at one year follow-up.
Koponen H; Reinikainen K; Riekkinen PJ
Psychol Med; 1990 Aug; 20(3):501-5. PubMed ID: 1978369
[TBL] [Abstract][Full Text] [Related]
20. Low somatostatin content in cerebrospinal fluid in multiple sclerosis. An indicator of disease activity?
Sørensen KV; Christensen SE; Dupont E; Hansen AP; Pedersen E; Orskov H
Acta Neurol Scand; 1980 Mar; 61(3):186-91. PubMed ID: 6104886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
